Lease commitments:

12 Months Ended

Feb. 29, 2016

5.Lease commitments:

Dr. Burzynski leases certain equipment used in the clinical trials under leases originally maturing in one to four years. Rent expense incurred under these leases was approximately $93,325 and $92,034 for the years ended February 29, 2016 and February 28, 2015, respectively.

Future minimum lease payments for the one year subsequent to February 29, 2016 are as follows:

2017	$	20,172
Thereafter	—

	$	20,172

In addition, as explained in Note 2, Dr. Burzynski owns the facility used by the Company to perform research and produce its drug products. There is currently no lease agreement; however, the facility’s costs are included in the accompanying financial statements as rental expense. The rental expense is derived from not only utilities and expenses normally incurred by a tenant but also mortgage interest, insurance, property taxes and building depreciation. Rent expense totaled $280,303 and $279,743 for 2016 and 2015, respectively.